Mackay Shields LLC’s Acacia Research ACTG Stock Holding History

Mackay Shields LLC’s Portfolio ACTG Stock Details ACTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-28,900	Closed	-$120K	–	1101
2018 Q2	$120K	Buy	+28,900	New	+$111K	﹤0.01%	1188

Other funds holding ACTG

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return

Mackay Shields LLC's ACTG Position: Q3 2018 in Review

Mackay Shields LLC sold out of Acacia Research (ACTG) in Q3 2018, closing a stake of 28,900 shares — an estimated $120K sold.

Mackay Shields LLC first reported a position in ACTG in Q2 2018 and held it in 1 quarter. The position peaked at $120K in Q2 2018. 91 funds tracked by Wall St. Rank hold ACTG as of Q3 2018.

Mackay Shields LLC reported no remaining Acacia Research position as of Q3 2018 after selling out during the quarter.
Mackay Shields LLC sold 28,900 Acacia Research shares in Q3 2018, an estimated $120K.
Mackay Shields LLC first reported a position in Acacia Research in Q2 2018 and held it in 1 quarter.
Mackay Shields LLC's Acacia Research position peaked at $120K in Q2 2018.
91 funds tracked by Wall St. Rank held Acacia Research as of Q3 2018.

Based on Mackay Shields LLC's 13F filing for Q3 2018, filed 14 Nov 2018.